Home

Home one

Where others see stumbling blocks,

Leaders see stepping stones...

Meet our new PSN officers...

Meet our new PSN officers...

DR. VICTOR DOCTOR
Secretary

Dr. GINA NAZARETH
Vice President

DR. ROBERTO TANCHANCO
Treasurer

Dr. SUSAN DELA RAMA
Immediate Past President

DR. CORALIE DIMACALI
President

New Website Features

Made Faster

More Visual

More Mobile

More Social

DOH alerts public on recalled Meparin 5 & Meparin 25

Advisories

Following the reports of unusually high incidences of chills in several dialysis centers in Manila, Bulacan, Valenzuela and Batangas, the Food & Drug Administration (FDA) after due investigations has issued a recall order on the blood anti-coagulant Meparin 5 and Meparin 25. This brand of Heparin Sodium manufactured by MedChem International Ltd has been found to have been contaminated by an undisclosed bacterial specie. Further investigations on other parenteral products of MedChem are underway.

 

The Department of Health (DOH) therefore enjoins all hospitals, dialysis centers and clinics to refrain from using Meparin 5 and Meparin 25, and to report to the FDA or DOH any suspicious clustering of symptoms such as the those experienced by the hospitals & dialysis centers in the above-mentioned areas.

 

Consumers may contact Pharma-Surrey International Inc at telephone number +6324128364, or e-mail at pharmasurrey@yahoo.com. Consumer may also email the FDA at info@fda.gov.ph for any question or additional information regarding the product recall.

 


Related References

Full details of the FDA Advisory

 

Read More

Upcoming Events

Renal Week 2014

Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN) & Renal Society of Australasia Annual Conference

Melbourne, Australia

Aug 25 - 27, 2014

More info: http://renalweek2014.org

Stay informed with the latest news. Subscribe with your email address to stay up to date with PSN.